γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
复制标题
DOI:
10.1016/j.peptides.2010.08.025
复制
发表时间:
2010-12
期刊:
影响因子:
3
通讯作者:
Haskell-Luevano C
中科院分区:
文献类型:
--
作者:
Joseph CG;Yao H;Scott JW;Sorensen NB;Marnane RN;Mountjoy KG;Haskell-Luevano C
The melanocortin system has been implicated in a multitude of physiological pathways including obesity, satiety, energy homeostasis, sexual behavior, pigmentation, sodium regulation, hypertension, and many others. Based upon studies of the endogenous melanocortin receptor agonists at the cloned human melanocortin receptor proteins, it was concluded that the γ-MSH related agonist ligands are selective for the MC3 versus the MC4 and MC5 receptors. In attempts to understand and identify the specific amino acids of γ2-MSH important for MC3R selectivity, we have performed N- and C-terminal truncation studies and pharmacologically characterized twenty-eight ligands at the mouse MC1 and MC3-5 melanocortin receptors. The C-terminal Trp-Asp9-Arg10-Phe11 residues are important for nM potency at the mMC3R and the Arg7-Trp8 residues are important for mMC5R nM potency. We observed the unanticipated results that several of the C-terminal truncated analogues possessed nM agonist potency at the mMC3 and mMC5Rs which lead us to performed a comparative side-by-side study of the mouse and human MC5R. These data resulted in μM γ2-MSH analogue potency at the hMC5R, consistent with previous reports, however at the mMC5R, nM γ2-MSH analogue potency was observed. Thus, these data support the hypothesis of important species specific differences in γ-MSH related ligand potency at the rodent versus human MC5R subtype that is critical for the interpretation of in vivo rodent physiological studies. These results prompted us to examine the affects of a peripherally administered melanocortin agonist on hypothalamic gene expression levels of the MC3R, MC4R, and MC5R. The super potent non-selective NDP-MSH agonist was administered i.p. and resulted in significantly decreased levels of mMC3R and mMC5R hypothalamic mRNA versus saline control. These data provide for the first time data demonstrating peripherally administered NDP-MSH can modify hypothalamic melanocortin receptor expression levels.
登录
查看更多内容
影响因子:
2.9
作者:
CHEN, WB;SHIELDS, TS;CONE, RD
通讯作者:
CONE, RD
DOI:
10.1006/bbrc.1993.2125
发表时间:
1993-09-15
影响因子:
3.1
作者:
CHHAJLANI, V;MUCENIECE, R;WIKBERG, JES
通讯作者:
WIKBERG, JES
影响因子:
7.3
作者:
Cai, MY;Mayorov, AV;Hruby, VJ
通讯作者:
Hruby, VJ
DOI:
10.1034/j.1399-3011.2002.01966.x
发表时间:
2002-05-01
期刊:
JOURNAL OF PEPTIDE RESEARCH
影响因子:
--
作者:
Grieco, P;Balse-Srinivasan, P;Hruby, VJ
通讯作者:
Hruby, VJ
影响因子:
7.3
作者:
Grieco, P;Balse, PM;Hruby, VJ
通讯作者:
Hruby, VJ